Cargando…
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer
Macrolide antibiotics, such as Clarithromycin (Cla), have been proven to exert anti-tumour activity in several preclinical models of different types of cancer. Cla can exert its anti-tumour effects through different mechanisms, e.g. by blocking the autophagic flux, inducing apoptosis or inhibiting t...
Autores principales: | Petroni, Giulia, Stefanini, Matteo, Pillozzi, Serena, Crociani, Olivia, Becchetti, Andrea, Arcangeli, Annarosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727004/ https://www.ncbi.nlm.nih.gov/pubmed/31508470 http://dx.doi.org/10.1016/j.dib.2019.104406 |
Ejemplares similares
-
Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020) -
Correction: Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020) -
The combined activation of K(Ca)3.1 and inhibition of K(v)11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
por: Pillozzi, Serena, et al.
Publicado: (2018) -
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
por: Crociani, Olivia, et al.
Publicado: (2013) -
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels
por: Pillozzi, S, et al.
Publicado: (2016)